LOCUS       NP_000015                413 aa                     PRI 04-MAY-2014
DEFINITION  beta-2 adrenergic receptor [Homo sapiens].
ACCESSION   NP_000015
VERSION     NP_000015.1  GI:4501969
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 413)
  AUTHORS   Frey UH, Karlik J, Herbstreit F and Peters J.
  TITLE     beta2-Adrenoceptor gene variants affect vasopressor requirements in
            patients after thoracic epidural anaesthesia
  JOURNAL   Br J Anaesth 112 (3), 477-484 (2014)
   PUBMED   24366725
  REMARK    GeneRIF: The ADRB2 Glu27 allele is an independent predictor of
            arterial hypotension and vasopressor requirements after thoracic
            epidural anaesthesia
REFERENCE   2  (residues 1 to 413)
  AUTHORS   Corominas R, Yang X, Lin GN, Kang S, Shen Y, Ghamsari L, Broly M,
            Rodriguez M, Tam S, Trigg SA, Fan C, Yi S, Tasan M, Lemmens I, Kuang
            X, Zhao N, Malhotra D, Michaelson JJ, Vacic V, Calderwood MA, Roth
            FP, Tavernier J, Horvath S, Salehi-Ashtiani K, Korkin D, Sebat J,
            Hill DE, Hao T, Vidal M and Iakoucheva LM.
  TITLE     Protein interaction network of alternatively spliced isoforms from
            brain links genetic risk factors for autism
  JOURNAL   Nat Commun 5, 3650 (2014)
   PUBMED   24722188
  REMARK    Publication Status: Online-Only
REFERENCE   3  (residues 1 to 413)
  AUTHORS   Bonini M, Permaul P, Kulkarni T, Kazani S, Segal A, Sorkness CA,
            Wechsler ME and Israel E.
  TITLE     Loss of salmeterol bronchoprotection against exercise in relation to
            ADRB2 Arg16Gly polymorphism and exhaled nitric oxide
  JOURNAL   Am. J. Respir. Crit. Care Med. 188 (12), 1407-1412 (2013)
   PUBMED   24228710
  REMARK    GeneRIF: The loss of bronchoprotection that occurs with chronic
            long-acting beta2-agonists use in exercise-induced
            bronchoconstriciton is not affected by ADRB2 Arg16Gly polymorphisms.
REFERENCE   4  (residues 1 to 413)
  AUTHORS   Ring AM, Manglik A, Kruse AC, Enos MD, Weis WI, Garcia KC and
            Kobilka BK.
  TITLE     Adrenaline-activated structure of beta2-adrenoceptor stabilized by
            an engineered nanobody
  JOURNAL   Nature 502 (7472), 575-579 (2013)
   PUBMED   24056936
  REMARK    GeneRIF: crystal structures of the active-state human beta2AR bound
            to three chemically distinct agonists: the ultrahigh-affinity
            agonist BI167107, the high-affinity catecholamine agonist
            hydroxybenzyl isoproterenol, and the low-affinity endogenous agonist
            adrenaline
REFERENCE   5
  AUTHORS   Matsuoka,S., Ballif,B.A., Smogorzewska,A., McDonald,E.R. III,
            Hurov,K.E., Luo,J., Bakalarski,C.E., Zhao,Z., Solimini,N.,
            Lerenthal,Y., Shiloh,Y., Gygi,S.P. and Elledge,S.J.
  TITLE     ATM and ATR substrate analysis reveals extensive protein networks
            responsive to DNA damage
  JOURNAL   Science 316 (5828), 1160-1166 (2007)
   PUBMED   17525332
REFERENCE   6
  AUTHORS   Thibonnier,M., Coles,P., Thibonnier,A. and Shoham,M.
  TITLE     Molecular pharmacology and modeling of vasopressin receptors
  JOURNAL   Prog. Brain Res. 139, 179-196 (2002)
   PUBMED   12436935
REFERENCE   7
  AUTHORS   Fredericks,Z.L., Pitcher,J.A. and Lefkowitz,R.J.
  TITLE     Identification of the G protein-coupled receptor kinase
            phosphorylation sites in the human beta2-adrenergic receptor
  JOURNAL   J. Biol. Chem. 271 (23), 13796-13803 (1996)
   PUBMED   8662852
REFERENCE   8
  AUTHORS   Baltensperger,K., Karoor,V., Paul,H., Ruoho,A., Czech,M.P. and
            Malbon,C.C.
  TITLE     The beta-adrenergic receptor is a substrate for the insulin receptor
            tyrosine kinase
  JOURNAL   J. Biol. Chem. 271 (2), 1061-1064 (1996)
   PUBMED   8557631
REFERENCE   9  (residues 1 to 413)
  AUTHORS   Parola AL and Kobilka BK.
  TITLE     The peptide product of a 5' leader cistron in the beta 2 adrenergic
            receptor mRNA inhibits receptor synthesis
  JOURNAL   J. Biol. Chem. 269 (6), 4497-4505 (1994)
   PUBMED   8308019
REFERENCE   10  (residues 1 to 413)
  AUTHORS   Gope R, Gope ML, Thorson A, Christensen M, Smyrk T, Chun M, Alvarez
            L, Wildrick DM and Boman BM.
  TITLE     Genetic changes at the beta-2-adrenergic receptor locus on
            chromosome 5 in human colorectal carcinomas
  JOURNAL   Anticancer Res. 11 (6), 2047-2050 (1991)
   PUBMED   1663718
REFERENCE   11  (residues 1 to 413)
  AUTHORS   Bouvier M, Guilbault N and Bonin H.
  TITLE     Phorbol-ester-induced phosphorylation of the beta 2-adrenergic
            receptor decreases its coupling to Gs
  JOURNAL   FEBS Lett. 279 (2), 243-248 (1991)
   PUBMED   1848190
REFERENCE   12
  AUTHORS   Bouvier,M., Guilbault,N. and Bonin,H.
  TITLE     Phorbol-ester-induced phosphorylation of the beta 2-adrenergic
            receptor decreases its coupling to Gs
  JOURNAL   FEBS Lett. 279 (2), 243-248 (1991)
   PUBMED   1848190
REFERENCE   13  (residues 1 to 413)
  AUTHORS   Yang-Feng TL, Xue FY, Zhong WW, Cotecchia S, Frielle T, Caron MG,
            Lefkowitz RJ and Francke U.
  TITLE     Chromosomal organization of adrenergic receptor genes
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 87 (4), 1516-1520 (1990)
   PUBMED   2154750
REFERENCE   14
  AUTHORS   O'Dowd,B.F., Hnatowich,M., Caron,M.G., Lefkowitz,R.J. and Bouvier,M.
  TITLE     Palmitoylation of the human beta 2-adrenergic receptor. Mutation of
            Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated
            form of the receptor
  JOURNAL   J. Biol. Chem. 264 (13), 7564-7569 (1989)
   PUBMED   2540197
REFERENCE   15  (residues 1 to 413)
  AUTHORS   Emorine LJ, Marullo S, Delavier-Klutchko C, Kaveri SV,
            Durieu-Trautmann O and Strosberg AD.
  TITLE     Structure of the gene for human beta 2-adrenergic receptor:
            expression and promoter characterization
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 84 (20), 6995-6999 (1987)
   PUBMED   2823249
REFERENCE   16  (residues 1 to 413)
  AUTHORS   Bucens,D. and Pain,M.C.
  TITLE     Influence of hematocrit, blood gas tensions, and pH on pressure-flow
            relations in the isolated canine lung
  JOURNAL   Circ. Res. 37 (5), 588-596 (1975)
   PUBMED   154
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from DA705141.1, BC073856.1,
            M15169.1, BC012481.2 and AA886615.1.
            This sequence is a reference standard in the RefSeqGene project.
            Summary: This gene encodes beta-2-adrenergic receptor which is a
            member of the G protein-coupled receptor superfamily. This receptor
            is directly associated with one of its ultimate effectors, the
            class C L-type calcium channel Ca(V)1.2. This receptor-channel
            complex also contains a G protein, an adenylyl cyclase,
            cAMP-dependent kinase, and the counterbalancing phosphatase, PP2A.
            The assembly of the signaling complex provides a mechanism that
            ensures specific and rapid signaling by this G protein-coupled
            receptor. This gene is intronless. Different polymorphic forms,
            point mutations, and/or downregulation of this gene are associated
            with nocturnal asthma, obesity and type 2 diabetes. [provided by
            RefSeq, Jul 2008].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            ##RefSeq-Attributes-START##
            regulatory uORF :: PMID: 8308019
            ##RefSeq-Attributes-END##
FEATURES             Location/Qualifiers
     source          1..413
                     /db_xref="taxon:9606"
                     /organism="Homo sapiens"
                     /chromosome="5"
                     /map="5q31-q32"
     Protein         1..413
                     /note="catecholamine receptor; beta-2 adrenoceptor; beta-2
                     adrenoreceptor; adrenergic, beta-2-, receptor, surface;
                     adrenoceptor beta 2 surface"
                     /product="beta-2 adrenergic receptor"
                     /calculated_mol_wt="46426"
     Site            35..58
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /site_type="transmembrane region"
     Region          48..340
                     /note="Serpentine type 7TM GPCR chemoreceptor Srsx;
                     pfam10320"
                     /db_xref="CDD:255903"
                     /region_name="7TM_GPCR_Srsx"
     Region          57..326
                     /note="7 transmembrane receptor (rhodopsin family);
                     pfam00001"
                     /db_xref="CDD:249497"
                     /region_name="7tm_1"
     Site            72..95
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /site_type="transmembrane region"
     Site            107..129
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /site_type="transmembrane region"
     Site            132
                     /db_xref="HPRD:00975"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[8]"
                     /site_type="phosphorylation"
     Site            141
                     /note="Phosphotyrosine; propagated from
                     UniProtKB/Swiss-Prot (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /site_type="phosphorylation"
     Site            141
                     /db_xref="HPRD:00975"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[8]"
                     /site_type="phosphorylation"
     Site            151..174
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /site_type="transmembrane region"
     Region          193..207
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /region_name="Agonist and antagonist binding"
     Site            197..220
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /site_type="transmembrane region"
     Site            246
                     /note="Phosphoserine; propagated from UniProtKB/Swiss-Prot
                     (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /site_type="phosphorylation"
     Site            246
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[5]"
                     /site_type="phosphorylation"
     Site            261
                     /db_xref="HPRD:01501"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[11]"
                     /site_type="phosphorylation"
     Site            262
                     /db_xref="HPRD:01501"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[11]"
                     /site_type="phosphorylation"
     Site            275..298
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /site_type="transmembrane region"
     Region          286..293
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /region_name="Agonist and antagonist binding"
     Site            306..329
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /site_type="transmembrane region"
     Region          312..316
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /region_name="Agonist and antagonist binding"
     Site            326
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[6]"
                     /site_type="phosphorylation"
     Site            341
                     /note="palmitoylation site"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[14]"
                     /site_type="modified"
     Site            345
                     /note="Phosphoserine, by PKA; propagated from
                     UniProtKB/Swiss-Prot (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /site_type="phosphorylation"
     Site            345
                     /db_xref="HPRD:01501"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[11]"
                     /site_type="phosphorylation"
     Site            346
                     /note="Phosphoserine, by PKA; propagated from
                     UniProtKB/Swiss-Prot (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /site_type="phosphorylation"
     Site            346
                     /db_xref="HPRD:01501"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[11]"
                     /site_type="phosphorylation"
     Site            350
                     /db_xref="HPRD:00975"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[8]"
                     /site_type="phosphorylation"
     Site            354
                     /db_xref="HPRD:00975"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[8]"
                     /site_type="phosphorylation"
     Site            364
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[8]"
                     /site_type="phosphorylation"
     Site            382
                     /note="4-hydroxyproline; propagated from
                     UniProtKB/Swiss-Prot (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /site_type="hydroxylation"
     Site            384
                     /db_xref="HPRD:02926"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[7]"
                     /site_type="phosphorylation"
     Site            393
                     /db_xref="HPRD:02926"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[7]"
                     /site_type="phosphorylation"
     Site            395
                     /note="4-hydroxyproline; propagated from
                     UniProtKB/Swiss-Prot (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /site_type="hydroxylation"
     Site            396
                     /db_xref="HPRD:02926"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[7]"
                     /site_type="phosphorylation"
     Site            401
                     /db_xref="HPRD:02926"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[7]"
                     /site_type="phosphorylation"
     Site            407
                     /db_xref="HPRD:02926"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[7]"
                     /site_type="phosphorylation"
     Region          410..413
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /region_name="PDZ-binding"
     Site            411
                     /db_xref="HPRD:02926"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[7]"
                     /site_type="phosphorylation"
     CDS             1..413
                     /coded_by="NM_000024.5:240..1481"
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /db_xref="CCDS:CCDS4292.1"
                     /db_xref="GeneID:154"
                     /db_xref="HGNC:HGNC:286"
                     /db_xref="HPRD:00187"
                     /db_xref="MIM:109690"
ORIGIN
        1 mgqpgngsaf llapnrshap dhdvtqqrde vwvvgmgivm slivlaivfg nvlvitaiak
       61 ferlqtvtny fitslacadl vmglavvpfg aahilmkmwt fgnfwcefwt sidvlcvtas
      121 ietlcviavd ryfaitspfk yqslltknka rviilmvwiv sgltsflpiq mhwyrathqe
      181 aincyanetc cdfftnqaya iassivsfyv plvimvfvys rvfqeakrql qkidksegrf
      241 hvqnlsqveq dgrtghglrr sskfclkehk alktlgiimg tftlcwlpff ivnivhviqd
      301 nlirkevyil lnwigyvnsg fnpliycrsp dfriafqell clrrsslkay gngyssngnt
      361 geqsgyhveq ekenkllced lpgtedfvgh qgtvpsdnid sqgrncstnd sll
//
